Home Tags SURMOUNT-1 Study

Tag: SURMOUNT-1 Study

Tirzepatide Cuts Type 2 Diabetes Risk by 94% in Obese Adults...

0
In a groundbreaking 176-week SURMOUNT-1 Phase 3 study, Eli Lilly's tirzepatide significantly reduced the risk of developing type 2 diabetes by 94% in adults...
15,925FansLike
1,951FollowersFollow
155SubscribersSubscribe
Global Market Updates

EDITOR PICKS